Cancer Targeted Technology develops specific imaging agents and personalized therapy for cancer that accurately detect advanced disease, monitor treatment efficacy and improve patient survival and quality of life.

CTT is pioneering the development of novel drug products targeting pivotal enzyme targets in cancer. We are searching for highly qualified individuals who are looking to make a difference in improving people's lives while working in a motivated and enthusiastic start-up environment. CTT offers an exciting opportunity for growth and development and competitive salary.

For more information, please contact:

CTT is currently seeking contracts with consultants who have experience in radiodiagnostics or radiotherapy specializing in regulatory affairs, manufacturing and toxicology.

Clinical Research Associate:

CTT is seeking a clinical research associate (CRA) to work with University of California, San Francisco to help  with the evaluation, initiation and management of a Phase 1 clinical trial. The CRA will assist in writing and designing study plans and eCRFs, conduct site initiation, conduct interim clinical monitoring and close out visits, assist in reporting any safety events associated with a clinical trial  and assist with the auditing and reconciliation of all study related documents for trials. The CRA will also help assemble study reports as needed and help identify and resolve clinical study issues. Prior experience as a clinical research associate is essential.  This is a home-based contract position.

Consultant, Toxicology:
The consultant will review plans for non-clinical toxicology programs designed to support FDA filings for the CTT’s radiotherapeutic and radiodiagnostic programs, monitor toxicology programs and assist with files as necessary at the request of CTT staff. Consultant will also be responsible for selection and oversight of CRO's. 

Program Manager/Director:

We are looking for a fulltime Program Manager/Director who can work on a development plan for our PET imaging agent in non-prostate cancer and work with our licensing partner on developing the PET imaging agent for prostate cancer. This person will also oversee a program to develop a targeted chemotherapy in prostate cancer.   The person will lead and write new grant submissions, manage current contract laboratories, and manage our current licensing partner.   The Program Manager/Director will appropriately utilize business contractors to drive our diagnostic and therapeutic programs into and through clinical trials, NDAs, and ultimately to market approval. For more details, see